Nanoplasmonic biosensors for precision medicine

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Molecular Diagnostics

Background:

• Precision medicine requires advanced diagnostic tools for molecular-level disease understanding.
• Traditional biosensors often lack the sensitivity, speed, and portability needed for widespread clinical use.
• Nanoplasmonic biosensors offer a promising alternative, meeting demands for low-cost, rapid, and portable detection with high sensitivity and multiplexing capabilities.

Purpose of the Study:

• To review common localized surface plasmon resonance (LSPR) detection schemes in nanoplasmonic biosensors.
• To highlight recent advancements and applications of nanoplasmonic sensing integrated with other methods.
• To discuss the current and potential applications of nanoplasmonic biosensors in precision medicine.

Main Methods:

• Review of literature on nanoplasmonic biosensor principles and LSPR detection.
• Analysis of integrated sensing strategies combining nanoplasmonics with techniques like isothermal amplification, CRISPR/Cas, lab-on-a-chip, and ELISA.
• Examination of nanoplasmonic biosensor applications in precision medicine, including DNA mutation detection, vaccine evaluation, and drug delivery.

Main Results:

• LSPR-based detection schemes are central to nanoplasmonic biosensor functionality.
• Integration of nanoplasmonics with other sensing methods enhances performance and expands application scope.
• Nanoplasmonic biosensors show significant potential in diverse precision medicine areas, from diagnostics to therapeutic monitoring.

Conclusions:

• Nanoplasmonic biosensors are crucial for advancing precision medicine through enhanced molecular diagnostics.
• Overcoming current obstacles in nanoplasmonic biosensor technology will further unlock their potential in healthcare.
• Continued research and development promise to solidify the role of nanoplasmonic biosensors in personalized treatment strategies.